Back to results
US 12,357,560 B2Granted
Composition for treating or preventing skin pigmentation
AssigneeShiseido Company, Ltd.
InventorsSayaka Koide, Masaya Takagi, Shoko Yamada, Ritsuro Ideta, Takashi Satoh
Life of this patent
Estimating the term…
Abstract
The present invention provides a composition for treating or preventing skin pigmentation, which contains fibroblasts as an active ingredient, wherein the fibroblasts are those fibroblasts which are less damaged than fibroblasts localized in a site where the skin pigmentation occurs, and the composition is characterized by being intended to be applied to a site where the pigmentation occurs or a dermis tissue around the site.
Claims4
A method for treatment of skin pigmentation of a subject in need thereof, the method comprising:
- applying fibroblasts as an active ingredient to a site of skin pigmentation or a surrounding dermal tissue of the subject, wherein:
- the fibroblasts are fibroblasts with less damage than fibroblasts localized at the site of skin pigmentation,
- the fibroblasts have lower expression of a cell senescence marker than fibroblasts localized at the site of skin pigmentation,
- the fibroblasts are derived from a tissue selected from the group consisting of a gluteal region, an abdominal region, a thorax, a femoral region, an upper arm, a dorsal region, a gingiva, an oral mucosa, a scalp, and an auricle rear,
- the cell senescence marker is one or more selected from the group consisting of senescent acidic β-galactosidase (SA-βgal), cell cycle check mechanism-associated factor and cell senescence-associated secretory phenotype (SASP) factor, and
- the skin pigmentation is caused by activated melanocytes induced by photo damaged-fibroblasts.
3 more elements
Dependencies are inferred from the claim text.